Inventor
CECILIA M. BASTOS
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds27%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium23%
A61KPreparations for medical, dental or toiletry purposes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07BGeneral methods of organic chemistry14%
PatentTitleYear
12,319,698Proteasome activity enhancing compounds202511,958,873Proteasome activity enhancing compounds202411,560,385Proteasome activity enhancing compounds202311,248,010Compounds, compositions, and methods for modulating CFTR202211,242,361Proteasome activity enhancing compounds202211,136,313Compounds, compositions, and methods for modulating CFTR2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to PROTEOSTASIS THERAPEUTICS INC (4)· patent assignee history
2021–2025Based in US· patent location history
2024–2025Patents assigned to KINETA INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PROTEOSTASIS THERAPEUTICS INC | 4 | 2021–2023 |
| KINETA INC | 2 | 2024–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2025 |